Facebook CEO's talk: Mark Zuckerberg plans to tell you how social network is going to give your privacy back. Brian Moynihan• Most recent annual compensation: $22.8 million• Company: Bank of America Corp.• Revenue: $100.3 billion• Number of employees: 209,376, 17. Whether or not such a pay gap is justified is a matter of debate. Because software company Oracle has two CEOs, 101 CEOs are included on this list. David Abney• Most recent annual compensation: $15.1 million• Company: UPS• Revenue: $65.9 billion• Number of employees: 346,415, 69. Stock granted in the past may vest in waves, or a CEO may buy new shares by exercising options awarded previously. Bioscience & Technology Business CenterThe University of KansasLawrence, Kansas. Timothy Wentworth• Most recent annual compensation: $15.9 million• Company: Express Scripts Holding (since acquired by Cigna)• Revenue: $100.1 billion• Number of employees: 26,600, 64. With regulators, drugmakers and payers pulling in similar directions, real-world evidence is likely to become a more central feature of drug development despite its many shortcomings. Samuel Allen• Most recent annual compensation: $18.5 million• Company: Deere• Revenue: $29.7 billion• Number of employees: 60,476, 44. "Even when they're comparable, what's the conclusion? At some companies, the CEO listed in the most recent proxy no longer holds the top job and is listed as retired. Tuyen Ong considers himself a bit of a nomad. CEO compensation: These CEOs make 1,000 times more than their employees, Tesla CEO: Elon Musk and SEC reach agreement over executive’s use of Twitter, companies where CEOs make over 1,000 times what their employees make. Reproduction in whole or part is prohibited. His family members include his parents' father, Albert Gorsky, and mother Loretta Gorsky and five siblings. Of this total $1,650,000 was received as a salary, $3,690,971 was received as a bonus, $4,049,997 was received in stock options, $9,956,365 was awarded as stock … That's because biotech workforces, particularly those filled with scientists and researchers, are well paid: median compensation topped $200,000 at nearly half of the 124 companies reporting data. After conducting a large clinical trial looking into remdesivir and three other treatments, the WHO has found that none had any substantial effect on improving mortality rates, reducing the amount of patients needing ventilators or shortening hospital stays. But they've since gained back more than they lost as progress on treatments and vaccines has raised the industry's profile. David Solomon• Most recent annual compensation: $20.7 million• Company: Goldman Sachs Group• Revenue: $42.3 billion• Number of employees: 36,600, 30. R.M. Andrew Cecere• Most recent annual compensation: $13.4 million• Company: U.S. Bancorp• Revenue: $24.0 billion• Number of employees: 72,402, 80. Unlock this story instantly and join 91,600+ biopharma pros reading Endpoints daily — and it's free. A new WHO study is throwing cold water on the effectiveness on remdesivir in Covid-19 patients. Pietro Satriano• Most recent annual compensation: $8.6 million• Company: US Foods Holding• Revenue: $24.1 billion• Number of employees: 25,204, 98. Illustration by Danielle Ternes/BioPharma Dive. Sales of the drug had previously factored in AbbVie's calculations for determining short-term bonuses for its executives, including Gonzalez. When Ong looks back at his career, he says he can see how all the dots connected to lead him to this point. This year, Johnson & Johnson and Biogen both noted in proxy statements that their directors would consider how executive incentives might influence decisions on drug pricing. But Sanofi is pursuing a variety of approaches to Covid-19, including an alliance with GSK on a more traditional approach to vaccine development. And he’s way ahead of last-place finisher Emma Walmsley, with a $7.67 million compensation package at GSK. Along with releasing 2020 guidance in January, Gorsky touted the company's new launches. Its big drug Xarelto saw a significant dip in sales in Q4 due to discounting. Compared to top CEOs in other industries, biopharmaceutical executives aren't necessarily outliers, however. Richard Gonzalez• Most recent annual compensation: $21.3 million• Company: AbbVie• Revenue: $28.2 billion• Number of employees: 29,000, 26. Squeri• Most recent annual compensation: $17.3 million• Company: American Express• Revenue: $35.6 billion• Number of employees: 55,000, 53. More companies, she said, are now setting expectations that growth will come from higher volumes of their drugs being prescribed, rather than from higher prices. Alex Gorsky with his family (Source: .jnj.com) His family members are hardworking; they work in the healthcare field. 2019 listed compensation is for the CEO who held the position at year end. Darren Woods• Most recent annual compensation: $18.8 million• Company: Exxon Mobil• Revenue: $244.4 billion• Number of employees: 71,200, 39. With only a few exceptions, the largest companies report CEO compensation packages of at least seven figures. The company is early in its rollouts for depression spray Spravato and cancer med Balversa, plus it’s submitting applications for new uses for Stelara, Darzalex, Erleada and other drugs. Emerging targets like KRAS, MET and RET are inspiring novel kinase inhibitor development and fueling billions in pharma deals. Tim Cook• Most recent annual compensation: $15.7 million• Company: Apple• Revenue: $229.2 billion• Number of employees: 123,000, 66. We'll e-mail you a link to set a new password. We first merged the list of companies included in the SPDR S&P Biotech exchange traded fund with a similar list for the iShares Nasdaq Biotechnology Index. In this scatter plot, CEO pay (on the y axis) is plotted against employee pay (on the x axis). Timothy Sloan• Most recent annual compensation: $18.4 million (stepped down)• Company: Wells Fargo• Revenue: $97.7 billion• Number of employees: 262,700, 45. Early last year, for example, Democratic Senator Ron Wyden of Oregon grilled AbbVie CEO Richard Gonzalez on whether the executive would make more money if the company raised the price of its topseller, the anti-inflammatory medicine Humira. As it stands, Gorsky is both CEO and chair, and Trillum says requiring an independent chair would improve the board's functioning. In 2020, J&J sees sales between $85.8 billion to $86.6 billion, leaving aside currency effects. The ratio roughly describes how many times greater CEO pay is than employee pay. And that clears the way to a Phase I/II launch before the end of this year. UroGen CEO Elizabeth Barrett, for instance, was granted 317,000 shares in the company and an option to purchase 277,000 more as a one-time "sign-on" award valued at roughly $24 million — 35 times her base salary. Johnson & Johnson CEO Alex Gorsky secured $9.96 million in stock awards and $4.05 million in options for 2019, both a bit smaller than the awards he snared for 2018. Lance• Most recent annual compensation: $23.4 million• Company: ConocoPhillips• Revenue: $32.6 billion• Number of employees: 11,400, 14. Enclose phrases in quotes. The free newsletter covering the top industry headlines. Alex Gorsky, Johnson & Johnson — $20 million. In 2018, Gorsky was paid a total of $20.1 million with no increase in deferred compensation and pension value. Mark Parker• Most recent annual compensation: $9.5 million• Company: Nike• Revenue: $34.4 billion• Number of employees: 74,400, 96. (The CEO of Starbucks, to use one notable example, made 1,675 times what the median barista earned last year.). The prostate cancer drug Zytiga, however, wasn't so fortunate, thanks to generic competition. Christopher Crane• Most recent annual compensation: $15.6 million• Company: Exelon• Revenue: $33.5 billion• Number of employees: 34,621, 67. * = partial year as CEO. Edward Bastian• Most recent annual compensation: $13.2 million• Company: Delta Air Lines• Revenue: $41.2 billion• Number of employees: 86,564, 82. Thomas Kennedy• Most recent annual compensation: $16.3 million• Company: Raytheon• Revenue: $25.3 billion• Number of employees: 64,000, 61. Oscar Munoz• Most recent annual compensation: $10.5 million• Company: United Continental Holdings• Revenue: $37.7 billion• Number of employees: 89,800, 94. Dennis Muilenburg• Most recent annual compensation: $23.4 million• Company: Boeing• Revenue: $93.4 billion• Number of employees: 140,800, 15. Can biopharma recover? ENDPOINTS by John Carroll & team — all the news at 11:30a ET, EARLY EDITIONby Arsalan Arif — skimmable links and news at 7:15a ET, New Dewpoint Therapeutics CEO Ameet Nathwani (Sanofi), Daniel O'Day, Gilead CEO (Kevin Dietsch/UPI/Bloomberg via Getty Images), Tuyen Ong, Flagship CEO-partner and Ring Therapeutics CEO (Flagship), by Arsalan Arif — skimmable links and news at 7:15a ET, J&J chief Alex Gorsky suffers a big drop in compensation, but still comes out way ahead of most major league CEOs. 100. New research provides more context, Give up board chairmanship? Thomas Wilson• Most recent annual compensation: $18.7 million• Company: Allstate• Revenue: $38.5 billion• Number of employees: 42,680, 42. By contrast, the median pharma employee is comparatively less well compensated than those of many biotechs. Lynn Good• Most recent annual compensation: $14.0 million• Company: Duke Energy• Revenue: $23.2 billion• Number of employees: 29,060, 77. Steven Collis• Most recent annual compensation: $11.5 million• Company: AmerisourceBergen• Revenue: $153.1 billion• Number of employees: 19,500, 90. Alex Gorsky (born May 24, 1960) is chairman and CEO of Johnson & Johnson, and chairman of the executive committee, the company's senior leadership team.He is the seventh person to serve as chair and CEO of Johnson & Johnson since it became a publicly traded company in 1944. Eli Lilly is snapping up a little Cambridge-based biotech to add to their neuro group. David Wichmann• Most recent annual compensation: $17.4 million• Company: UnitedHealth Group• Revenue: $201.2 billion• Number of employees: 260,000, 51. Pharma CEOs are usually paid more than what other CEOs in the industry typically make, sometimes substantially so. When biotech and pharmaceutical CEOs have been scrutinized for their pay packages, it's often been tied to questions of whether drug price increases play a role. He had been at Novartis for 7 years, which followed an earlier chapter in research at Teva. © 2020 Questex LLC. Safra Catz• Most recent annual compensation: $108.3 million (tie)• Company: Oracle• Revenue: $37.7 billion• Number of employees: 138,000, 1. Vivera Pharmaceuticals Announces Two New Antigen Tests for COVID-19. Chief executives of drugmakers large and small received hefty pay increases over the past two years, shaking off persistent public criticism of the industry to capitalize on strong stock market performance. R. Stephenson• Most recent annual compensation: $29.1 million• Company: AT&T• Revenue: $160.5 billion• Number of employees: 254,000, 5. Marillyn Hewson• Most recent annual compensation: $21.5 million• Company: Lockheed Martin• Revenue: $51.0 billion• Number of employees: 100,000, 23. If you're already an Endpoints subscriber, enter your email below for a magic link that lets you sign in quickly without using a password. In terms of salary, Gorsky's base pay remained flat at $1.65 million in 2019, and his stock and option awards came in slightly lower than in the previous year, but his cash incentive pay rang in at $3.69 million, a slight increase. And today they’ve moved in to buy the whole thing. Alex was born on 24 May 1960. Further, Trillum pointed to some of J&J’s recent controversies as evidence the company could use better oversight. Like the rest of the top 15 players in the business, J&J has to contend with some fierce blowback on US prices.
Caitlin Innes Edwards Bio, Betty White 2020, Is Chile Or Argentina Safer, When You Need Me Meaning, Cardi B - Pull Up Lyrics, Jeremy Renner Heaven Don't Have A Name, Lowest Football Ground In Scotland, Valarie Pettiford, Django Crosby,